Dicyclomine HCl and Simethicone Suspension

Description

Vaxpas is a combination gastrointestinal medicine containing Dicyclomine HCl and Simethicone.  Dicyclomine HCl present in the suspension provides relief from abdominal cramps and spasms, while Simethicone helps to manage gas, bloating, and related digestive discomfort. Its liquid form makes it easy to consume, especially when a liquid dosage form is preferred. With growing demand for digestive medicines, Pharvax Biosciences offers Vaxspas for businesses looking to develop a focused and diverse PCD Pharma Franchise product portfolio. This product can be a valuable addition to a gastrointestinal medicine range, as its combined formulation gives it a practical position in the GI and digestive-care segment. 

PCD Pharma Franchise Opportunity for Dicyclomine HCl and Simethicone Suspension – Pharvax Biosciences

Pharvax Biosciences offers Dicyclomine HCl and Simethicone Suspension under their brand name Vaxpas for PCD pharma franchise and pharmaceutical distribution opportunities across India. Pharma franchise partners can include this product in their portfolio to expand their range of gastrointestinal medicines, digestive-care products, antispasmodic medicines, and anti-gas formulations. Along with this, Pharvax Biosciences also offers a wide range of pharmaceutical products across different therapeutic segments and dosage forms. The company focuses on quality manufacturing, product availability, monopoly rights, and marketing support to help its PCD franchise partners grow their business.

Key Features of Vaxpas Suspension

Vaxpas Suspension contains Dicyclomine HCl and Simethicone, which work in different ways to help manage common digestive discomfort.

• Dicyclomine HCl helps relax gastrointestinal muscles and ease abdominal spasms.
• Simethicone helps reduce gas-related discomfort and bloating.
• Vaxspas can be included in gastrointestinal, digestive-care, antispasmodic, and stomach-care product portfolios.
• The suspension is a convenient option for people who may have difficulty taking tablets or capsules.
• It can help pharma franchise businesses expand their range with a commonly relevant gastrointestinal medicine.